We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
Icahn School of Medicine at Mount Sinai
New York, New York
|Credit Amount:||0.5 Credits|
|Estimated Time for Completion:||30 minutes|
|Cost:||Free of charge|
Expert commentary is based on data presented at the 25th European Academy of Dermatology and Venereology Congress*
In this activity, a renowned dermatologist discusses new data for current and emerging atopic dermatitis treatments recently presented at the 25th European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria.
Upon completion of this activity, participants will be able to:
This activity has been designed to meet the educational needs of dermatologists, allergist/immunologists, and other clinicians involved in the management of patients with atopic dermatitis.
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Enduring Material
Release and Expiration Dates: October 28, 2016- October 27, 2017
Time to Complete: 30 minutes
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME activity for any amount during the past 12 months.
Emma Guttman-Yassky, MD, PhD
Professor and Vice Chair, Department of Dermatology
Professor of Medicine, Clinical Immunology
Director of the Center for Excellence in Eczema
Director of the Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York, New York
Emma Guttman-Yassky, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant for AbbVie; Almirall; Anacor Pharmaceuticals Inc.; Asana BioSciences, LLC.; Celgene Corporation; Dermiria, Inc.; Galderma; Glenmark Pharmaceuticals Ltd.; Kyowa Hakko Kirin Co., Ltd.; LEO Pharma Inc.; Lilly; MedImmune; Mitsubishi Tanabe Pharma Corporation; Novartis Pharmaceuticals Corporation; Pfizer; Regeneron Pharmaceuticals, Inc.; Sanofi-Aventis; Stiefel Laboratories, Inc./GlaxoSmithKline; and Vitae Pharmaceuticals, Inc.
Grant/Research Support from Celgene Corporation; Glenmark Pharmaceuticals Ltd.; Janssen Biotech, Inc.; Lilly; LEO Pharma Inc.; MedImmune; and Regeneron Pharmaceuticals, Inc.
Emma Guttman-Yassky, MD, PhD, does intend to discuss either non−FDA-approved or investigational use for the following products/devices: investigational agents and off-label therapies for the treatment of atopic dermatitis.
Matthew A. Goodman, MD
Attending Physician Internal Medicine
Abington Jefferson Health
Maple Glen, Pennsylvania
Matthew A. Goodman, MD, has no financial interests/relationships or affiliations in relation to this activity.
Tracy L. Greene, MSN, RN, NP-C
Tracy L. Greene, MSN, RN, NP-C, has no financial interests/relationships or affiliations in relation to this activity.
Kate Nelson, PhD
PVI, PeerView Institute for Medical Education
Kate Nelson, PhD, has no financial interests/relationships or affiliations in relation to this activity.
The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.|
This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.
This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
*PeerView Press is an independent publisher of conference news and medical education programs.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.
Copyright © 2000-2016, PeerView Press - Medical Education Resource
"OpenCME has initially been made available in a "beta" edition with minimal content, functionality and online presence. Our editorial team is working hard to add many other specialty areas to the list above."
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.